Oligonucleotide Synthesis Market Report
First published: 15 October 2024 | Last updated: 28 May 2026 | Report Code: oligonucleotide-synthesis
Oligonucleotide Synthesis Market — USD 2.1 billion in 2023, Growing to USD 4.78B by 2033 at 8.3% CAGR
This report provides an in-depth analysis of the Oligonucleotide Synthesis market, covering trends, segmentation, regional insights, and forecasts from 2023 to 2033.
Key Takeaways
- Global market expands from $2.10 Billion in 2023 to $4.78 Billion in 2033 at an 8.3% CAGR.
- Europe is largest regional market; Middle East and Africa is regional market region based on implied CAGR across 2023 to 2033.
- Middle East and Africa is the regional market region, rising from $0.2 Billion to $0.47 Billion (implied 8.92% CAGR).
- North America grows from $0.69 Billion in 2023 to $1.58 Billion in 2033, reflecting sustained demand.
- Key vendors include Thermo Fisher Scientific, Integrated DNA Technologies (IDT), Eurofins Genomics, and Sigma-Aldrich (Merck KGaA).
Oligonucleotide Synthesis Market Report — Executive Summary
Regional analysis shows Europe as largest market and Middle East and Africa as fastest-growing region by implied CAGR. The Oligonucleotide Synthesis market is driven by rising investments in genetic research, expanding diagnostic applications, and advances in automated synthesis platforms. The market value moves from $2.10 Billion in 2023 to $4.78 Billion by 2033 at an 8.3% CAGR for 2023 to 2033. Regional dynamics show Europe as the largest market and Middle East and Africa as the regional market region. Segmentation covers product types, technologies, applications, and end users including academic and research institutions, pharmaceutical and biotechnology companies, and diagnostic laboratories. Leading companies such as Thermo Fisher Scientific and Integrated DNA Technologies (IDT) are active in innovation and partnerships. The report emphasizes technological improvements, increasing demand for custom oligonucleotides, and the role of next-generation synthesis methods in expanding capacity and application scope.
Key Growth Drivers
- Increased funding and activity in genomic and genetic research driving demand for custom oligonucleotides.
- Broader adoption of molecular diagnostics expanding the need for synthesized oligonucleotides in clinical workflows.
- Technological advances in automation and next-generation synthesis improving throughput and reducing turnaround times.
- Growing use of oligonucleotides in therapeutic research and personalized medicine initiatives.
- Rising collaborations between academic institutions, biotech firms, and large service providers enhancing solution availability.
| Metric | Value |
|---|---|
| Study Period | 2023 - 2033 |
| 2023 Market Size | $2.10 Billion |
| CAGR (2023-2033) | 8.3% |
| 2033 Market Size | $4.78 Billion |
| Top Companies | Thermo Fisher Scientific, Integrated DNA Technologies (IDT), Eurofins Genomics, Sigma-Aldrich (Merck KGaA) |
| Published Date | 15 October 2024 |
| Last Modified Date | 28 May 2026 |
Oligonucleotide Synthesis Market Overview
Customize Oligonucleotide Synthesis Market Report market research report
- ✔ Get in-depth analysis of Oligonucleotide Synthesis market size, growth, and forecasts.
- ✔ Understand Oligonucleotide Synthesis's regional dynamics and industry-specific trends.
- ✔ Identify potential applications, end-user demand, and growth segments in Oligonucleotide Synthesis
What is the Market Size & CAGR of Oligonucleotide Synthesis Market Report market in 2023?
Oligonucleotide Synthesis Industry Analysis
Oligonucleotide Synthesis Market Segmentation and Scope
Tell us your focus area and get a customized research report.
Oligonucleotide Synthesis Market Report Market Analysis Report by Region
Europe Oligonucleotide Synthesis Market Report:
Europe is largest regional market, rising from $0.72 Billion in 2023 to $1.65 Billion in 2033. The region’s growth reflects robust research ecosystems, investments in diagnostics and therapeutics, and active participation from contract service and reagent suppliers.Asia Pacific Oligonucleotide Synthesis Market Report:
Asia Pacific grows from $0.39 Billion in 2023 to $0.89 Billion in 2033. Growth stems from expanding research capacity, rising biotech investment, and greater adoption of molecular and diagnostic technologies across emerging markets.North America Oligonucleotide Synthesis Market Report:
North America grows from $0.69 Billion in 2023 to $1.58 Billion in 2033. Regional demand is propelled by strong biopharma activity, investment in genomic research, and the presence of established service providers supplying custom and pre-synthesized oligonucleotides.South America Oligonucleotide Synthesis Market Report:
Latin America grows from $0.09 Billion in 2023 to $0.2 Billion in 2033. Market expansion is linked to developing research infrastructure, growing diagnostic uptake, and increasing collaborations with global suppliers.Middle East & Africa Oligonucleotide Synthesis Market Report:
Middle East and Africa is fastest-growing region by implied CAGR, increasing from $0.2 Billion in 2023 to $0.47 Billion in 2033. This regional growth market benefits from rising investments in healthcare and research capabilities, along with expanding demand for diagnostic and therapeutic oligonucleotide applications.Tell us your focus area and get a customized research report.
Research Methodology
Oligonucleotide Synthesis Market Analysis By Product Type
In 2023, the custom oligonucleotides market is valued at USD 1.42 billion and is projected to grow to USD 3.24 billion by 2033, capturing about 67.72% of the total market share. Pre-synthesized oligonucleotides hold a market size of USD 0.61 billion, expected to expand to USD 1.38 billion by 2033, accounting for 28.89% of the market...
Oligonucleotide Synthesis Market Analysis By Technology
The market for PCR Technology in 2023 is noted at USD 1.42 billion with a projected CAGR that would bring it to USD 3.24 billion by 2033, making it a predominant segment at 67.72% market share. Synthesis Technology follows at USD 0.61 billion for 2023, growing to USD 1.38 billion by the end of the forecast period, making up 28.89% of the market.
Oligonucleotide Synthesis Market Analysis By Application
Oligonucleotide Synthesis in diagnostic applications holds a commanding market share at USD 1.42 billion in 2023. This segment is expected to grow to USD 3.24 billion by 2033, maintaining a major influence with 67.72%. Therapeutic applications are poised for growth from USD 0.61 billion to USD 1.38 billion, representing 28.89% of the application scope.
Oligonucleotide Synthesis Market Analysis By End User
Academic and research institutions lead the market with a valuation of USD 1.20 billion in 2023, set to reach USD 2.73 billion by 2033. The pharmaceutical industries currently stand at USD 0.52 billion and are expected to grow to USD 1.19 billion over the same period.
Oligonucleotide Synthesis Market Analysis By Region
Global Oligonucleotide Synthesis Market, By Region Market Analysis (2023 - 2033)
Regional analysis highlights North America as a leader in market size, with Europe and Asia Pacific following due to rising healthcare innovations. The Middle East and Africa show slower growth but increasing influence owing to improving healthcare infrastructure.
Oligonucleotide Synthesis Market Trends and Future Forecast
Tell us your focus area and get a customized research report.
Global Market Leaders and Top Companies in Oligonucleotide Synthesis Industry
Thermo Fisher Scientific:
A leading company in the field, Thermo Fisher Scientific provides comprehensive solutions for nucleic acid synthesis and related technologies, focusing on innovation and quality.Integrated DNA Technologies (IDT):
IDT specializes in custom DNA and RNA oligonucleotides with a commitment to providing high-quality products and exceptional customer service.Eurofins Genomics:
Known for its extensive oligonucleotide synthesis and genomic services, Eurofins Genomics aims to support research and therapeutic applications globally.Sigma-Aldrich (Merck KGaA):
Merck's Sigma-Aldrich division offers a wide range of oligonucleotide synthesis services, focusing on biotech and pharma industries.We're grateful to work with incredible clients.
FAQs
What is the market size of the oligonucleotide synthesis market in 2023?
The market size in 2023 is $2.10 Billion, reflecting current demand from research, diagnostics, and therapeutic development across multiple end users and technologies.
How big will the market be in 2033?
The market reaches $4.78 Billion by 2033, indicating continued expansion driven by technological improvements and increasing applications in diagnostics and therapeutics.
What is CAGR of the market for the forecast period?
The compound annual growth rate for 2023 to 2033 is 8.3%, representing steady expansion supported by research investment and automation in synthesis processes.
Which region is the fastest Growing in the Oligonucleotide Synthesis Market Report market?
Middle East and Africa is the fastest-growing region, projected to expand from $0.2 Billion in 2023 to $0.47 Billion in 2033, reflecting an implied 8.92% CAGR over the forecast period.
Which region is the fastest Growing?
Middle East and Africa is identified as the regional market region, increasing from $0.2 Billion in 2023 to $0.47 Billion in 2033 at an implied 8.92% CAGR.
Who are the leading companies in this market?
Top companies listed include Thermo Fisher Scientific, Integrated DNA Technologies (IDT), Eurofins Genomics, and Sigma-Aldrich (Merck KGaA), active across synthesis and service offerings.
What applications drive demand for oligonucleotide synthesis?
Diagnostic, therapeutic, and research applications drive demand, with diagnostics and therapeutic research expanding the need for tailored oligonucleotide sequences.
How do end users shape market development?
Academic and research institutions, pharmaceutical industries, biotechnology companies, and diagnostic laboratories drive requirements for custom and pre-synthesized oligonucleotides.